Product Information
CALCIUM ACETATE 667 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.1733 per EA under NDC 69097086283. Its NADAC has been published 511 times since Sep 14, 2016.
Strength
667 mg/1
Manufacturer
Cipla USA Inc.NDC
69097086283
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CALCIUM ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA203135On Market Since
7/26/2016
Pharmacological Classes
Price Statistics
The NADAC for CALCIUM ACETATE 667 MG CAPSULE has been published 511 times since Sep 14, 2016, and over the history we have for it it has declined 51.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1733 per EA |
|---|---|
| All-time high | $0.5239 (Jul 15, 2020) |
| All-time low | $0.1369 (Nov 20, 2024) |
| 52-week high | $0.2245 |
| 52-week low | $0.1722 |
| Median price | $0.2186 |
| Average price | $0.2507 |
| Largest weekly change | +38.0% (May 13, 2020) |
| Weeks tracked | 511 |
| Tracking since | Sep 14, 2016 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CALCIUM ACETATE 667 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CALCIUM ACETATE 667 MG CAPSULE, manufactured by Cipla USA Inc., is $0.1733 per EA (NDC 69097086283), effective Jun 24, 2026.
How has the price of CALCIUM ACETATE 667 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CALCIUM ACETATE 667 MG CAPSULE has declined 51.1%. It has been tracked across 511 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for CALCIUM ACETATE 667 MG CAPSULE?
Since Sep 14, 2016, the NADAC for CALCIUM ACETATE 667 MG CAPSULE has ranged from a low of $0.1369 (Nov 20, 2024) to a high of $0.5239 (Jul 15, 2020), with a median of $0.2186 per EA.
Are there cheaper alternatives to CALCIUM ACETATE 667 MG CAPSULE?
8 NADAC-published products share the same active ingredient, strength, and dosage form as CALCIUM ACETATE 667 MG CAPSULE, but none are currently priced below it.
Who manufactures CALCIUM ACETATE 667 MG CAPSULE?
CALCIUM ACETATE 667 MG CAPSULE (NDC 69097086283) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification